7-45890680-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000596.4(IGFBP1):c.482C>T(p.Ser161Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,610,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000596.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IGFBP1 | NM_000596.4 | c.482C>T | p.Ser161Leu | missense_variant | 2/4 | ENST00000275525.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IGFBP1 | ENST00000275525.8 | c.482C>T | p.Ser161Leu | missense_variant | 2/4 | 1 | NM_000596.4 | P4 | |
IGFBP1 | ENST00000457280.5 | c.482C>T | p.Ser161Leu | missense_variant | 2/4 | 5 | A2 | ||
IGFBP1 | ENST00000468955.1 | c.482C>T | p.Ser161Leu | missense_variant | 2/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152076Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 247914Hom.: 0 AF XY: 0.00000746 AC XY: 1AN XY: 134040
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1458428Hom.: 0 Cov.: 31 AF XY: 0.0000193 AC XY: 14AN XY: 725404
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152194Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74400
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2022 | The c.482C>T (p.S161L) alteration is located in exon 2 (coding exon 2) of the IGFBP1 gene. This alteration results from a C to T substitution at nucleotide position 482, causing the serine (S) at amino acid position 161 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at